Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000363100 | SCV000343501 | pathogenic | not provided | 2016-06-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001204274 | SCV001375473 | pathogenic | Alagille syndrome due to a JAG1 point mutation | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser131Valfs*13) in the JAG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with JAG1-related conditions. ClinVar contains an entry for this variant (Variation ID: 289187). For these reasons, this variant has been classified as Pathogenic. |